The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer
Abstract
Purpose To develop a radiomics signature to estimate disease-free survival (DFS) in patients with early-stage (stage I–II) non–small cell lung cancer (NSCLC) and assess its incremental value to the traditional staging system and clinical-pathologic risk factors for individual DFS estimation. Materials and Methods Ethical approval by the institutional review board was obtained for this retrospective analysis, and the need to obtain informed consent was waived. This study consisted of 282 consecutive patients with stage IA–IIB NSCLC. A radiomics signature was generated by using the least absolute shrinkage and selection operator, or LASSO, Cox regression model. Association between the radiomics signature and DFS was explored. Further validation of the radiomics signature as an independent biomarker was performed by using multivariate Cox regression. A radiomics nomogram with the radiomics signature incorporated was constructed to demonstrate the incremental value of the radiomics signature to the traditional staging system and other clinical-pathologic risk factors for individualized DFS estimation, which was then assessed with respect to calibration, discrimination, reclassification, and clinical usefulness. Results The radiomics signature was significantly associated with DFS, independent of clinical-pathologic risk factors. Incorporating the radiomics signature into the radiomics-based nomogram resulted in better performance (P < .0001) for the estimation of DFS (C-index: 0.72; 95% confidence interval [CI]: 0.71, 0.73) than with the clinical-pathologic nomogram (C-index: 0.691; 95% CI: 0.68, 0.70), as well as a better calibration and improved accuracy of the classification of survival outcomes (net reclassification improvement: 0.182; 95% CI: 0.02, 0.31; P = .02). Decision curve analysis demonstrated that in terms of clinical usefulness, the radiomics nomogram outperformed the traditional staging system and the clinical-pathologic nomogram. Conclusion The radiomics signature is an independent biomarker for the estimation of DFS in patients with early-stage NSCLC. Combination of the radiomics signature, traditional staging system, and other clinical-pathologic risk factors performed better for individualized DFS estimation in patients with early-stage NSCLC, which might enable a step forward precise medicine. © RSNA, 2016 Online supplemental material is available for this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341
Radiomics: extracting more information from medical images using advanced feature analysis
Lambin, P., Rios-Velazquez, E., Leijenaar, R., Carvalho, S., van Stiphout, R. G. P. M., Granton, P., Zegers, C. M. L., Gillies, R., Boellard, R., Dekker, A., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.036 · Cited by 6,084
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Evaluating the Yield of Medical Tests
Harrell, F. E. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320430047030 · Cited by 3,490
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Radiomics: the process and the challenges
Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S. A., Schabath, M. B., Forster, K., Aerts, H. J. W. L., Dekker, A., Fenstermacher, D., et al. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.010 · Cited by 2,258
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Cited by
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Liu, Z., Wang, S., Dong, D., Wei, J., Fang, C., Zhou, X., Sun, K., Li, L., Li, B., Wang, M., et al. (2019) · Theranostics · doi:10.7150/thno.30309 · Cited by 967
Self-citationPredicting cancer outcomes with radiomics and artificial intelligence in radiology
Bera, K., Braman, N., Gupta, A., Velcheti, V., & Madabhushi, A. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00560-7 · Cited by 819
Xu, X., Zhang, H.-L., Liu, Q.-P., Sun, S.-W., Zhang, J., Zhu, F.-P., Yang, G., Yan, X., Zhang, Y.-D., & Liu, X.-S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.023 · Cited by 706
A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme
Lao, J., Chen, Y., Li, Z.-C., Li, Q., Zhang, J., Liu, J., & Zhai, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10649-8 · Cited by 630
Zhang, B., Tian, J., Dong, D., Gu, D., Dong, Y., Zhang, L., Lian, Z., Liu, J., Luo, X., Pei, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2910 · Cited by 494
Self-citationBeyond imaging: The promise of radiomics
Avanzo, M., Stancanello, J., & El Naqa, I. (2017) · Physica Medica · doi:10.1016/j.ejmp.2017.05.071 · Cited by 483
Radiomics and radiogenomics in lung cancer: A review for the clinician
Thawani, R., McLane, M., Beig, N., Ghose, S., Prasanna, P., Velcheti, V., & Madabhushi, A. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2017.10.015 · Cited by 450
Ahmad, A., Imran, M., & Ahsan, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061630 · Cited by 386
Deep learning with convolutional neural network in radiology
Yasaka, K., Akai, H., Kunimatsu, A., Kiryu, S., & Abe, O. (2018) · Japanese Journal of Radiology · doi:10.1007/s11604-018-0726-3 · Cited by 368
Defining the biological basis of radiomic phenotypes in lung cancer
Grossmann, P., Stringfield, O., El-Hachem, N., Bui, M. M., Rios Velazquez, E., Parmar, C., Leijenaar, R. T., Haibe-Kains, B., Lambin, P., Gillies, R. J., et al. (2017) · eLife · doi:10.7554/elife.23421 · Cited by 365
Larue, R. T. H. M., Defraene, G., De Ruysscher, D., Lambin, P., & van Elmpt, W. (2017) · The British Journal of Radiology · doi:10.1259/bjr.20160665 · Cited by 363
Peng, H., Dong, D., Fang, M.-J., Li, L., Tang, L.-L., Chen, L., Li, W.-F., Mao, Y.-P., Fan, W., Liu, L.-Z., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3065 · Cited by 327
Self-citationYang, L., Gu, D., Wei, J., Yang, C., Rao, S., Wang, W., Chen, C., Ding, Y., Tian, J., & Zeng, M. (2019) · Liver Cancer · doi:10.1159/000494099 · Cited by 316
Self-citationChoe, J., Lee, S. M., Do, K.-H., Lee, G., Lee, J.-G., Lee, S. M., & Seo, J. B. (2019) · Radiology · doi:10.1148/radiol.2019181960 · Cited by 296
Park, J. E., Kim, D., Kim, H. S., Park, S. Y., Kim, J. Y., Cho, S. J., Shin, J. H., & Kim, J. H. (2020) · European Radiology · doi:10.1007/s00330-019-06360-z · Cited by 282
Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer
Zhang, Y., Oikonomou, A., Wong, A., Haider, M. A., & Khalvati, F. (2017) · Scientific Reports · doi:10.1038/srep46349 · Cited by 269
Jiang, Y., Chen, C., Xie, J., Wang, W., Zha, X., Lv, W., Chen, H., Hu, Y., Li, T., Yu, J., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.007 · Cited by 184
“[19,20,50,52] The least absolute shrinkage and selection operator (LASSO) method is a popular method for regression of high-dimensional predictors.”
MethodIdentification of non-small cell lung cancer sensitive to systemic cancer therapies using radiomics
Dercle, L., Fronheiser, M., Lu, L., Du, S., Hayes, W., Leung, D. K., Roy, A., Wilkerson, J., Guo, P., Fojo, A. T., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2942 · Cited by 177
Vaidya, P., Bera, K., Gupta, A., Wang, X., Corredor, G., Fu, P., Beig, N., Prasanna, P., Patil, P. D., Velu, P. D., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30002-9 · Cited by 134
“Al.(15) published a radiomic signature using a LASSO Cox-regression model constructed using 132 radiomic textures features from the histogram and grey-level co-occurrence matrix families, from within the node from N=282 ES-NSCLC patients.”
MethodNam, J. G., Park, S., Park, C. M., Jeon, Y. K., Chung, D. H., Goo, J. M., Kim, Y. T., & Kim, H. (2022) · Radiology · doi:10.1148/radiol.213262 · Cited by 32
Feng, B., Chen, X., Chen, Y., Li, Z., Hao, Y., Zhang, C., Li, R., Liao, Y., Zhang, X., Huang, Y., et al. (2019) · Clinical Radiology · doi:10.1016/j.crad.2019.03.018 · Cited by 28
Self-citationSimpson, G., Jin, W., Spieler, B., Portelance, L., Mellon, E., Kwon, D., Ford, J. C., & Dogan, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.807725 · Cited by 11
Liao, H., Li, Y., Yang, Y., Liu, H., Zhang, J., Liang, H., Yan, G., & Liu, Y. (2022) · Diagnostics · doi:10.3390/diagnostics12081915 · Cited by 10
Metadata
- Authors
- Huang, Y., Liu, Z., He, L., Chen, X., Pan, D., Ma, Z., Liang, C., Tian, J., & Liang, C.
- Venue
- Radiology
- Published
- 2016-12
- Volume
- 281
- Issue
- 3
- Pages
- 947-957
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2461805626
- Cited by
- 743
- References
- 37
- FWCI
- 50.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.